Executive Summary

Mar 2019
PROSPECTS
Brazilian government’s financial problems hinder the expansion of the public reimbursement system

The public reimbursement system in Brazil, which is part of the government’s Farmácia Popular programme and has included adult incontinence products since 2010, is suffering from the country’s fragile financial situation. Despite a more optimistic outlook for the economy, greater confidence in public finance will likely only be achieved if the current government passes long-awaited pension reforms, which are considered critical to driving economic growth and reducing the government’s deficit, enabling it to invest more in programmes such as Farmácia Popular.

Fragile public finances mean weak growth for the Rx/reimbursement channel when compared to retail

Adult incontinence in the retail channel posted double-digit volume growth in 2018, while the Rx/reimbursement channel registered only a modest increase, with this being down to the above-mentioned poor financial situation of the state and its municipalities. The category would have suffered a heavy decline if it were not for Sao Paulo state, which is the most populated and most affluent and thus compensated for weaker spending from other states.

Leading brand manufacturers see value in promoting Farmácia Popular

Despite the country’s financial problems, the largest manufacturers, Essity and Ontex, still regard Farmácia Popular as an important channel to increase the penetration of adult incontinence products, especially among families with lower incomes. Their direct communications with consumers aim to explain the programme, its rules and, more importantly, who is covered.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Rx/Reimbursement Adult Incontinence in Brazil

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase. 

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Brazil with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Brazil, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Brazil market research report includes:

  • Analysis of key supply-side and demand trends
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as: 

  • What is the market size of Rx/Reimbursement adult incontinence in Brazil?
  • What are the major brands in Brazil?
  • What are the most important channels for Rx/Reimbursement adult incontinence products?
  • How do light incontinence products perform compared to moderate/heavy incontinence products?
WHY BUY THIS REPORT?
  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our 

Tissue and Hygiene market research database

Rx/Reimbursement Adult Incontinence in Brazil - Category analysis

HEADLINES

PROSPECTS

Brazilian government’s financial problems hinder the expansion of the public reimbursement system
Fragile public finances mean weak growth for the Rx/reimbursement channel when compared to retail
Leading brand manufacturers see value in promoting Farmácia Popular

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2013-2018
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2013-2018
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2018-2023
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2018-2023

Tissue and Hygiene in Brazil - Industry Overview

EXECUTIVE SUMMARY

2018 proves a challenging year as a result of soaring raw material costs and political instability
Rising raw material costs lead to price increases
Further concentration expected in the competitive environment as consumption rises
Convenience and price shape consumer preference
Positive outlook should help support the development of more sustainable products

MARKET INDICATORS

Table 5 Birth Rates 2013-2018
Table 6 Infant Population 2013-2018
Table 7 Female Population by Age 2013-2018
Table 8 Total Population by Age 2013-2018
Table 9 Households 2013-2018
Table 10 Forecast Infant Population 2018-2023
Table 11 Forecast Female Population by Age 2018-2023
Table 12 Forecast Total Population by Age 2018-2023
Table 13 Forecast Households 2018-2023

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2013-2018
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2013-2018
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2014-2018
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2015-2018
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2013-2018
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2013-2018
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2018
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2018-2023
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2018-2023

SOURCES

Summary 1 Research Sources